ZFHX4 mutation as a novel predictive biomarker for immune checkpoint blockade in non-small cell lung cancer.

被引：0
|
作者：
Shen, Peng
Zeng, Di
Lin, Zhenzi
Lin, Pei
Luo, Mingyang
Zhao, Lele
Chai, Huizi
Huang, Lingli
Xiao, Mingzhe
机构：
[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Clin Med Sch 1, Guangzhou, Peoples R China
[3] Jiangsu Sim cere Diagnost Co Ltd, State Key Lab Translat Med & Innovat Drug Dev, Jiangsu Simcere Diagnost Co, Nanjing, Peoples R China
[4] Jiangsu Simcere Diagnost Co Ltd, Dept Med, Nanjing, Peoples R China
[5] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20535
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer
    Su, Chunxia
    Wang, Xinxin
    Zhou, Juan
    Zhao, Jing
    Zhou, Fei
    Zhao, Guodong
    Xu, Xiaohong
    Zou, Xuan
    Zhu, Bo
    Jia, Qingzhu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1256 - +
  • [42] RAD51Bme as predictive biomarker for PD-1 blockade response in non-small cell lung cancer.
    Guerreiro, Ines Maria
    Barros-Silva, Daniela
    Lopes, Paula
    Cunha, Ana Luisa
    Lobo, Joao
    Antunes, Luis
    Rodrigues, Ana
    Silva Soares, Marta Alexandra
    Henrique, Rui
    Jeronimo, Carmen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy
    Jain, Swati
    Ma, Kevin
    Morris, Luc G. T.
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (02) : 447 - 451
  • [44] Association between lung microbiome and immune checkpoint blockade response in non-small cell lung cancer patients
    Kim, Joon
    Yong, Seung-Hyun
    Kim, Eun Young
    Oh, Chang-Myung
    Lee, Sang Hoon
    RESPIROLOGY, 2024, 29 : 52 - 52
  • [45] Immune checkpoint blockade in small cell lung cancer
    Tay, Rebecca Y.
    Heigener, David
    Reck, Martin
    Califano, Raffaele
    LUNG CANCER, 2019, 137 : 31 - 37
  • [46] Novel predictors associated with therapeutic effects of immune checkpoint inhibitors on bone metastasis of non-small cell lung cancer.
    Asano, Yohei
    Yamamoto, Norio
    Hayashi, Katsuhiro
    Takeuchi, Akihiko
    Miwa, Shinji
    Igarashi, Kentaro
    Yonezawa, Hirotaka
    Morinaga, Sei
    Saito, Shiro
    Tsuchiya, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Spatial transcriptomics to profile the non-small cell lung cancer tumor microenvironment and identify novel predictive biomarkers for checkpoint blockade
    Cho, Christina
    Lopez, Francesc
    Woodard, Gavitt
    Huang, Baozhu
    He, Jianwei
    Badri, Tayf
    Kidacki, Michal
    Vesely, Matthew
    Ng, Evelyn
    Wang, Guilin
    Chen, Lieping
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [48] Superior efficacy of neoadjuvant compared to adjuvant immune checkpoint blockade in non-small cell lung cancer
    Cascone, Tina
    Hamdi, Haifa
    Zhang, Fahao
    Poteete, Alissa
    Li, Lerong
    Hudgens, Courtney W.
    Williams, Leila J.
    Wu, Qiuyu
    Gudikote, Jayanthi
    Peng, Weiyi
    Hwu, Patrick
    Wang, Jing
    Tetzlaff, Michael
    William, William N.
    Heymach, John V.
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancer
    Yoo, Shin Hye
    Keam, Bhumsuk
    Kim, Miso
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    THORACIC CANCER, 2018, 9 (06) : 736 - 744
  • [50] CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer
    Lau, Asa P. Y.
    Binstock, Sharon S. Khavkine
    Thu, Kelsie L.
    CANCERS, 2023, 15 (21)
12345